Investigators compared adverse effects of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines reported in the COVID Symptom Study App with those reported during phase 3 trials.
Investigators conducted a retrospective cohort study to determine the difference in COVID-19 outcomes in patients with HIV infection compared with those without HIV infection.
Researchers studied the impact of current opioid agonist therapy on initiation of chronic hepatitis C virus treatment among a population of individuals who inject drugs.
As HIV-exposed, uninfected infants have higher rates of morbidity and mortality than HIV-unexposed uninfected infants, a study was conducted to analyze whether particular infections or immune responses contribute to hospitalization.
A body of emerging research is attempting to quantify changes occurring as a result of the impact of COVID-19 on the HIV pandemic.
A team of investigators assessed the presence of enteropathogens in children with isolated vomiting.
Investigators sought to better understand the immunologic mechanisms behind increased susceptibility to secondary respiratory infections.
Study authors assessed aortic aneurysm and dissection risks after fluoroquinolone use in the United States.
Investigators used data from mothers and infants enrolled in the DolPHIN-1 trial to develop a population pharmacokinetic model of dolutegravir.
The authors emphasize that sepsis treatment should be guided by the connection between the microbiota and sepsis outcomes.
